Incyte stock heads into the open after a 0.5 percent drop
Published on 09/23/2026 at 03:30 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Incyte stock closed at USD 124.65 on Nasdaq on September 22, 2026, down 0.5 percent. The shares traded below their USD 132.60 52-week high, while the Nasdaq Composite rose 0.5 percent to 27,244.28 on the same session.
September 22, 2026 in numbers
Incyte Corporation (ISIN US45337C1027, Nasdaq: INCY) opened at USD 125.33 and closed at USD 124.65 on September 22, 2026. The session data also placed the stock below its 52-week high of USD 132.60 and above its 52-week low of USD 81.09.
RBC maintained a Sector Perform rating and a USD 109 price target, according to MarketBeat on September 22, 2026. Incyte also announced that portfolio data would be presented at the European Academy of Dermatology and Venereology Congress from September 30 through October 3, 2026, as reported by Business Wire.
EADV data event on September 30, 2026
Incyte is scheduled to present inflammation and autoimmunity data at the European Academy of Dermatology and Venereology Congress from September 30 through October 3, 2026, in Vienna, according to Investing.com. The event is the scheduled company-specific item within the next five trading days.
